Management of Central Diabetes Insipidus in Disabled Children with Diluted Oral Desmopressin Lyophilisate Formulation Administered Through Nasogastric Tube: A Retrospective Case Series
CONCLUSIONS: Nasogastric administration of oral DDAVP lyophilised formulation was safe and effective in the treatment of CDI in disabled children in this small retrospective series.PMID:37326929 | DOI:10.1007/s40272-023-00578-7 (Source: Paediatric Drugs)
Source: Paediatric Drugs - June 16, 2023 Category: Pediatrics Authors: H üseyin Anıl Korkmaz Ved Bhushan Arya Ahmet G önüllü Fulya Co şkunol Behzat Ozkan Source Type: research
Management of Central Diabetes Insipidus in Disabled Children with Diluted Oral Desmopressin Lyophilisate Formulation Administered Through Nasogastric Tube: A Retrospective Case Series
CONCLUSIONS: Nasogastric administration of oral DDAVP lyophilised formulation was safe and effective in the treatment of CDI in disabled children in this small retrospective series.PMID:37326929 | DOI:10.1007/s40272-023-00578-7 (Source: Paediatric Drugs)
Source: Paediatric Drugs - June 16, 2023 Category: Pediatrics Authors: H üseyin Anıl Korkmaz Ved Bhushan Arya Ahmet G önüllü Fulya Co şkunol Behzat Ozkan Source Type: research
Management of Central Diabetes Insipidus in Disabled Children with Diluted Oral Desmopressin Lyophilisate Formulation Administered Through Nasogastric Tube: A Retrospective Case Series
CONCLUSIONS: Nasogastric administration of oral DDAVP lyophilised formulation was safe and effective in the treatment of CDI in disabled children in this small retrospective series.PMID:37326929 | DOI:10.1007/s40272-023-00578-7 (Source: Paediatric Drugs)
Source: Paediatric Drugs - June 16, 2023 Category: Pediatrics Authors: H üseyin Anıl Korkmaz Ved Bhushan Arya Ahmet G önüllü Fulya Co şkunol Behzat Ozkan Source Type: research
Management of Central Diabetes Insipidus in Disabled Children with Diluted Oral Desmopressin Lyophilisate Formulation Administered Through Nasogastric Tube: A Retrospective Case Series
CONCLUSIONS: Nasogastric administration of oral DDAVP lyophilised formulation was safe and effective in the treatment of CDI in disabled children in this small retrospective series.PMID:37326929 | DOI:10.1007/s40272-023-00578-7 (Source: Paediatric Drugs)
Source: Paediatric Drugs - June 16, 2023 Category: Pediatrics Authors: H üseyin Anıl Korkmaz Ved Bhushan Arya Ahmet G önüllü Fulya Co şkunol Behzat Ozkan Source Type: research
Management of Central Diabetes Insipidus in Disabled Children with Diluted Oral Desmopressin Lyophilisate Formulation Administered Through Nasogastric Tube: A Retrospective Case Series
CONCLUSIONS: Nasogastric administration of oral DDAVP lyophilised formulation was safe and effective in the treatment of CDI in disabled children in this small retrospective series.PMID:37326929 | DOI:10.1007/s40272-023-00578-7 (Source: Paediatric Drugs)
Source: Paediatric Drugs - June 16, 2023 Category: Pediatrics Authors: H üseyin Anıl Korkmaz Ved Bhushan Arya Ahmet G önüllü Fulya Co şkunol Behzat Ozkan Source Type: research
Management of Central Diabetes Insipidus in Disabled Children with Diluted Oral Desmopressin Lyophilisate Formulation Administered Through Nasogastric Tube: A Retrospective Case Series
CONCLUSIONS: Nasogastric administration of oral DDAVP lyophilised formulation was safe and effective in the treatment of CDI in disabled children in this small retrospective series.PMID:37326929 | DOI:10.1007/s40272-023-00578-7 (Source: Paediatric Drugs)
Source: Paediatric Drugs - June 16, 2023 Category: Pediatrics Authors: H üseyin Anıl Korkmaz Ved Bhushan Arya Ahmet G önüllü Fulya Co şkunol Behzat Ozkan Source Type: research
Management of Central Diabetes Insipidus in Disabled Children with Diluted Oral Desmopressin Lyophilisate Formulation Administered Through Nasogastric Tube: A Retrospective Case Series
CONCLUSIONS: Nasogastric administration of oral DDAVP lyophilised formulation was safe and effective in the treatment of CDI in disabled children in this small retrospective series.PMID:37326929 | DOI:10.1007/s40272-023-00578-7 (Source: Paediatric Drugs)
Source: Paediatric Drugs - June 16, 2023 Category: Pediatrics Authors: H üseyin Anıl Korkmaz Ved Bhushan Arya Ahmet G önüllü Fulya Co şkunol Behzat Ozkan Source Type: research
Management of Central Diabetes Insipidus in Disabled Children with Diluted Oral Desmopressin Lyophilisate Formulation Administered Through Nasogastric Tube: A Retrospective Case Series
CONCLUSIONS: Nasogastric administration of oral DDAVP lyophilised formulation was safe and effective in the treatment of CDI in disabled children in this small retrospective series.PMID:37326929 | DOI:10.1007/s40272-023-00578-7 (Source: Paediatric Drugs)
Source: Paediatric Drugs - June 16, 2023 Category: Pediatrics Authors: H üseyin Anıl Korkmaz Ved Bhushan Arya Ahmet G önüllü Fulya Co şkunol Behzat Ozkan Source Type: research
Management of Central Diabetes Insipidus in Disabled Children with Diluted Oral Desmopressin Lyophilisate Formulation Administered Through Nasogastric Tube: A Retrospective Case Series
CONCLUSIONS: Nasogastric administration of oral DDAVP lyophilised formulation was safe and effective in the treatment of CDI in disabled children in this small retrospective series.PMID:37326929 | DOI:10.1007/s40272-023-00578-7 (Source: Paediatric Drugs)
Source: Paediatric Drugs - June 16, 2023 Category: Pediatrics Authors: H üseyin Anıl Korkmaz Ved Bhushan Arya Ahmet G önüllü Fulya Co şkunol Behzat Ozkan Source Type: research
Management of Central Diabetes Insipidus in Disabled Children with Diluted Oral Desmopressin Lyophilisate Formulation Administered Through Nasogastric Tube: A Retrospective Case Series
CONCLUSIONS: Nasogastric administration of oral DDAVP lyophilised formulation was safe and effective in the treatment of CDI in disabled children in this small retrospective series.PMID:37326929 | DOI:10.1007/s40272-023-00578-7 (Source: Paediatric Drugs)
Source: Paediatric Drugs - June 16, 2023 Category: Pediatrics Authors: H üseyin Anıl Korkmaz Ved Bhushan Arya Ahmet G önüllü Fulya Co şkunol Behzat Ozkan Source Type: research
Management of Central Diabetes Insipidus in Disabled Children with Diluted Oral Desmopressin Lyophilisate Formulation Administered Through Nasogastric Tube: A Retrospective Case Series
ConclusionsNasogastric administration of oral DDAVP lyophilised formulation was safe and effective in the treatment of CDI in disabled children in this small retrospective series. (Source: Pediatric Drugs)
Source: Pediatric Drugs - June 16, 2023 Category: Pediatrics Source Type: research
EULAR study group on 'MHC-I-opathy: identifying disease-overarching mechanisms across disciplines and borders
The ‘MHC-I (major histocompatibility complex class I)-opathy’ concept describes a family of inflammatory conditions with overlapping clinical manifestations and a strong genetic link to the MHC-I antigen presentation pathway. Classical MHC-I-opathies such as spondyloarthritis, Behcet’s disease, psoriasis and birdshot uveitis are widely recognised for their strong association with certain MHC-I alleles and gene variants of the antigen processing aminopeptidases ERAP1 and ERAP2 that implicates altered MHC-I peptide presentation to CD8+T cells in the pathogenesis. Progress in understanding the cause and trea...
Source: Annals of the Rheumatic Diseases - June 12, 2023 Category: Rheumatology Authors: Kuiper, J. J., Prinz, J. C., Stratikos, E., Kusnierczyk, P., Arakawa, A., Springer, S., Mintoff, D., Padjen, I., Shumnalieva, R., Vural, S., Kötter, I., van de Sande, M. G., Boyvat, A., de Boer, J. H., Bertsias, G., de Vries, N., Krieckaert, C. L. Tags: Open access, ARD Reviews Source Type: research
Cardiovascular risk in vasculitis
Best Pract Res Clin Rheumatol. 2023 Jun 9:101831. doi: 10.1016/j.berh.2023.101831. Online ahead of print.ABSTRACTThe present review summarizes the burden, risk factors, biomarkers of and therapeutic consideration for cardiovascular disease in systemic vasculitis. Ischemic heart disease (IHD) and stroke are intrinsic features of Kawasaki disease, Takayasu arteritis, Giant Cell Arteritis (GCA), and Behcet's disease. The risk of IHD and stroke is increased in anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) and cryoglobulinemic vasculitis. Behcet's disease could present with venous thromboembolism. The risk of...
Source: Cell Research - June 11, 2023 Category: Cytology Authors: Durga Prasanna Misra Aman Sharma George A Karpouzas George D Kitas Source Type: research
Identification of the immune-related biomarkers in Behcet's disease by plasma proteomic analysis
CONCLUSIONS: Our study not only revealed a distinctive immune response-related protein profile for BD but also showed that IL10, FCRL3, MASP1, NF2, FAM3B, and MGMT could serve as potential immune biomarkers for this disease. Additionally, a novel molecular disease classification model was constructed to identify subsets of BD.PMID:37264476 | DOI:10.1186/s13075-023-03074-y (Source: Cell Research)
Source: Cell Research - June 1, 2023 Category: Cytology Authors: Huan Liu Panpan Zhang Fuzhen Li Xiao Xiao Yinan Zhang Na Li Liping Du Peizeng Yang Source Type: research
Identification of the immune-related biomarkers in Behcet ’s disease by plasma proteomic analysis
This study aimed to investigate the expression profile of immune response-related proteins of Behcet ’s disease (BD) patients and identify potential biomarkers for this disease. (Source: Arthritis Research and Therapy)
Source: Arthritis Research and Therapy - June 1, 2023 Category: Rheumatology Authors: Huan Liu, Panpan Zhang, Fuzhen Li, Xiao Xiao, Yinan Zhang, Na Li, Liping Du and Peizeng Yang Tags: Research Source Type: research
